GlassScriptPhysician profile
Marcella R Guzman
NPI 1245396126
$4,937.14
in general payments reported to CMS, 2019-2025
10 companies · $842 in 2025
The $842 reported for 2025 was more than what 95% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $182 · 2021: $1,974 · 2022: $1,067 · 2024: $770 · 2025: $842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $620 · Education: $575 · Food and Beverage: $388 · Grant: $28.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $620.46 |
| Education | $575.00 |
| Food and Beverage | $388.45 |
| Grant | $28.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $2,274.36 | 2021-2025 | Opalescence |
| Straumann USA LLC | $820.72 | 2019-2024 | |
| Dentsply Sirona INC | $689.57 | 2019-2025 | Suresmile |
| Patterson Companies, INC. | $602.50 | 2021 | |
| Align Technology, INC. | $422.44 | 2019-2025 | Invisalign |
| 3m Company | $61.61 | 2020 | |
| Envista Holdings Corporation | $28.29 | 2024 | Harmonize |
| Philips North America LLC | $14.91 | 2022 | |
| Zimmer Biomet Holdings, INC. | $14.62 | 2021 | |
| Voco America INC. | $8.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcella Guzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.